O ne strategy for mapping blood pressure (BP) variants is by linkage analysis using inbred rat strains.
O ne strategy for mapping blood pressure (BP) variants is by linkage analysis using inbred rat strains. 1 Although useful, linkage analysis is limited to localizing a large (10-30 cM) quantitative trait locus (QTL) that is associated with BP, but cannot further reduce the list of potential causative variant(s) within the QTL. 2 Causative variant(s) can be further isolated by fixing portions of the QTL from 1 parental strain (donor) on the background of the other (recipient) to form a congenic strain. 2 Combined, these strategies have shown that many BP QTL actually contain multiple interdependent loci that can have additive, subtractive, or epistatic effects on BP. 3 Thus, capturing different portions of a QTL that contains multiple BP loci can often lead to unexpected results that are difficult to interpret. Such has been the case for the QTL containing the BP-mediator Renin.
In 1989, a region of rat chromosome 13 including the Renin gene was the first BP QTL to be mapped by linkage analysis. 4 Since then, these results were replicated 5 and confirmed in multiple other hypertensive strains. [6] [7] [8] [9] [10] Although the hypertensive Dahl salt-sensitive (SS) Renin allele cosegregated with elevated BP by linkage, 6 -10 the same has not been true for congenic strains that captured portions of the Renin QTL. For example, BP was unexpectedly elevated by a congenic interval containing the normotensive Dahl R (SR) Renin allele on the SS background, 11 whereas a reverse congenic (SS Renin on an SR background) surprisingly decreased BP. 12 Another SS-13 SR congenic strain showed that the SR Renin allele only reduced BP when downstream regions of the SR genome were present, 5 suggesting that other variant(s) downstream of Renin likely contribute to BP. Notably, each of these congenic strains also carried substantial amounts of undefined congenic interval owing to the limited availability of genotype markers at the time. 5, 11, 12 As such, the BP regulatory elements within the relatively large region of chromosome 13 that includes the Renin locus have remained largely unresolved.
In this study, we performed detailed mapping of a region of chromosome 13, including the Renin locus (chr13: 45.2-49.0 Mb) using SS-13 BN congenic strains. [13] [14] [15] This revealed a protective region (chr13: 46.1-47.2 Mb) promoting lower BP (referred to as line9 BP1 ) that is offset by an adjacent region promoting higher BP (chr13: 47.2-49.0 Mb; referred to as line9 BP2 ), both derived from the same strain. We also reanalyzed archived DNA from the hypertensive S/ren rr congenic strain (SR Renin on a SS background) used in a 1997 study published in Hypertension by Jiang et al. 11 This reduced by 85% the undefined congenic interval of S/ren rr , enabling us to compare overlapping sequence among SS, SR, and Brown Norway (BN) in our congenic region. By sequence comparison (SS, SR, and BN), we identified significantly enriched regions of common BN and SR alleles that overlapped with the 2 BP loci and are likely to be functionally relevant. We also identified regions of BN-and SR-specific alleles that could account for subtle differences in BP phenotypes between SS-13 BN and SS-13 SR congenic strains. Combined with 2 loci from previous studies, 16 ,17 these data demonstrate that at least 4 total BP loci reside in the SS Renin QTL.
Materials and Methods

Animals
All animal protocols were approved by the Institutional Animal Care and Use Committee of the Medical College of Wisconsin. Genomic boundaries for congenic lines 9, 9A, 9B, and 9C were described previously, 13 but have been further refined here (Figure 1 ). Line 9D was generated by backcrossing line 9 to SS/JrHsD/Mcwi.
BP Measurement
Mean arterial pressure (MAP) was measured by telemetry transmitter implantation with a catheter inserted into the abdominal aorta, as described previously.
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Measurement of Albumin Excretion
On day 16 of 8% NaCl diet, rats were acclimated in metabolic cages for 24 hours, followed by a 24-hour urine collection. Albuminuria was measured as described previously.
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Genomic Sequencing
Genomic sequence was accessed from the rat genome database (http://rgd.mcw.edu/). Full details of library preparation, sequencing, and analysis are described elsewhere.
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Statistical Analysis
Statistical analyses were performed using Sigma Plot 11.0 software. Data are presented as mean±SEM. All data were analyzed by 1-way ANOVA followed by the Holm-Sidak post hoc test.
Results
Blood Pressure
To narrow the regions around Renin that modify BP, a series of SS-13 BN congenic strains were generated and phenotyped for BP salt-sensitivity as depicted in Figure 1 . After 21 days of 8% NaCl diet, only the MAP of line 9A (147±11 mm Hg; P<0.05; n=13) was significantly less than parental SS (179±6 mm Hg; n=10) and lines 9 (176±6 mm Hg; n=10), 9B (172±4 mm Hg; n=24), 9C (169±6 mm Hg; n=21), and 9D (190±4 mm Hg; n=10; Figure 1 ). Because the protective line 9A is genetically identical to line 9 except from 47.2 to 49.0 Mb, these data suggest that hypertensive BN allele(s) reside within this 1. 
Renal Damage
To assess renal damage, albumin excretion was quantified from urine that was collected from SS and SS-13 BN congenic rats after 17 days of 8% NaCl diet. In agreement with MAP data, only line 9A rats (117±9 mg; P<0.05) had reduced albumin excretion compared with parental SS (231±30 mg) and lines 9 (243±30 mg), 9B (242±23 mg), 9C (242±25 mg), and 9D (320±29 mg; Figure 1 ). Also, similar to MAP, albumin excretion in line 9D trended higher than SS (320±29 versus 231±30 mg; Figure 1 ). Collectively, these data suggest that renal damage is secondary to BP in lines 9, 9A, 9B, 9C, and 9D and that the line 9 congenic interval (chr13: 45.2-49.0 Mb) does not harbor any additional loci for susceptibility to end-organ damage.
Sequence Analysis
Our data support that although a region of BN chromosome 13 including the Renin locus (46.1-47.2 Mb) is protective, a BN hypertensive locus (47.2-49.0 Mb) resides in close proximity ( Figure 1) . Similarly, Jiang et al 11 found evidence that a SR-derived hypertensive locus resides in an 8.7-Mb congenic interval surrounding Renin. They reported that the SR Renin region increased BP (Δ+30 mm Hg; P<0.05) in the SS-13 SR congenic (referred to as S/ren rr ) compared with SS ( Figure 2A) . 11 Also similar to line 9, 13,14 the S/ren rr congenic restores plasma renin activity, 19 angiogenesis, 19 and vasoreactivity, 20 indicating that line 9 and S/ren rr share some functional allele(s), but not all. Most notably, the protective region around Renin (46.1-47.2 Mb) did not offset the hypertensive BP allele(s) in S/ren rr , 11 as was detected in line 9 ( Figure 2 ). This suggests that the BN protective BP allele(s) in line 9 are not shared by SR in S/ren rr , whereas the hypertensive allele(s) are likely shared by BN and SR. In a previous study, only a restriction fragment length polymorphism in Renin 4 and 2 flanking simple sequence length polymorphism markers were available for genotyping S/ren rr , 11 leaving the entire 8.7-Mb region around Renin undefined as SS or SR ( Figure 2A ). We obtained archived DNA samples from the original congenic S/ren rr strain published in 1997 by Jiang et al 11 and narrowed the confidence intervals by >85% through regenotyping ( Figure 2B ). This increased the defined SR congenic interval to 1.9 Mb (chr13: 46 109 499-48 026 949 bp), which overlapped with the line 9 congenic interval, including the entire protective region (chr13:46.1-47.2 Mb) and 88% of the adjacent hypertensive region (chr13: 47.2-49.0 Mb).
We compared the SS/Jr (used by Jiang et al 11 ) , the SS/ JrMcwi (used for our SS-13 BN congenics), 13 the SR, and the BN genomic sequences across the entire 3.7-Mb line 9 congenic interval to identify common and unique variants among the strains (Table S2 in the online-only Data Supplement). Across the line 9 interval, only 2 variants (<0.0001%) were polymorphic between SS/Jr and SS/JrMcwi, and therefore, we hereafter use SS to denote both strains. In the SS, we identified 3691 variants that differed from BN and 2368 variants that differed from SR (Table S2 ). When combined, SS had 1003 variants that differed from both SR and BN (Table S2) .
To identify cosegregating and unique regions of the SR and BN genomes that could influence BP in the SS, we plotted the total unique and common variants per 100 kb in the SR and BN versus SS ( 
BP QTL Analysis
The following is a description of the protective region (line9 BP1 ) and the adjacent hypertensive region (line9 BP2 ):
Line9 BP1
The protective line9 BP1 region (chr13: 46.1-47.2 Mb) contains 17 validated genes and 6 predicted genes (Table S1) . Compared with BN, the line9 BP1 SS sequence contains 1433 variants, of which 16 lie in coding regions, 6 are nonsynonymous, and 4 are predicted to be damaging (Table) . Compared with SR, the line9 BP1 SS sequence has 251 variants, of which 7 reside in coding regions, 2 are nonsynonymous and are predicted to be damaging (Table) . Of the BN variants, 1180 are specific to only BN, of which 16 are coding, 6 are nonsynonymous, and 4 are predicted to be damaging (Table) . These BN-specific variants likely include the BP lowering allele(s) that were unique to the line 9 congenic interval and not observed in S/ren rr by Jiang et al 11 ( Figure 2 ). When combined, the SS had 267 variants that differed from both SR and BN, of which 1 nonsynonymous variant was predicted to be damaging. These common variants likely include shared SR and BN allele(s) that regulate renin expression, 13, 19 angiogenesis, 13, 19 and vasoreactivity 14, 20 that were restored in both line 9 and S/ren rr .
Line9 BP2
The hypertensive line9 BP2 region (chr13: 47 198 168-48 990 782 bp) contains 30 validated genes and 9 predicted genes (Table S1) . Compared with BN, the line9 BP2 SS sequence contains 2063 variants, of which 46 lie in coding regions, 14 are nonsynonymous, and 2 are predicted to be damaging (Table) . Compared with SR, the line9 BP2 SS sequence contains 2362 variants, of which 64 lie in coding regions, 12 are nonsynonymous, and 3 are predicted to be damaging. When combined SS had 987 variants that differed from both SR and BN, with 18 variants in coding regions, 8 nonsynonymous variants, of which 3 are predicted to be damaging (Table) . Of note, 7 of 8 nonsynonymous variants that were shared by BN and SR also resided in Ptprv and were located in the 47.6 to 48.4 region that was significantly enriched for common SR and BN alleles. Of these shared Ptprv variants, 1 variant was predicted to be damaging to Ptprv function (Figure 3 ; Table) .
Discussion
A RNO13 QTL-containing Renin has long been associated with BP in the rat, [4] [5] [6] [7] [8] [9] [10] [11] [12] but the genetic and molecular mechanism(s) underlying this relationship are largely unknown. Here, we showed for the first time that a BN hypertensive region (chr13: 47.2-49.0 Mb) resides near the protective BN region around Renin (chr13: 46.1-47.2 Mb; Figure 1 ). We refined a previously identified hypertensive SS-13 SR congenic strain, S/ren rr , 11 with an SR congenic interval similar to line 9 ( Figure 2 ). The elevated BP in line 9 and S/ren rr suggested that causative allele(s) are likely to be shared by SR and BN within the region (47.6-48.4 Mb) that was significantly enriched for common SR and BN polymorphisms (Figure 3) . By combining congenic mapping with strain sequence comparison, we were able to preliminarily reduce by 42% the number of candidate variants in this region. Finally, these data offer a more complete picture of multiple interdependent BP loci ( Figure 4 ) that reside within the Renin QTL, which was first described nearly 25 years ago.
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Is Renin a BP Candidate Gene?
Renin has historically been considered a BP candidate gene because of the physiological role of the renin-angiotensin system (RAS) in BP regulation and its strong association with BP in multiple models of genetic hypertension. [4] [5] [6] [7] [8] [9] [10] [11] [12] By congenic exclusion, our data suggest that the BN region around Renin (46.1-47.2 Mb) is responsible for the decreased BP observed in the line 9A congenic (Figure 1 ). At present, it remains unclear whether Renin is a causative BP gene in the RNO13 QTL in the SS rat. We confirmed that coding regions of the SS, SR, and BN Renin alleles did not differ (Table S1 ). However, differences in renin expression in SS, SR, and BN have been previously reported 13, 21 and as such, allele-specific changes in Renin expression/activity remain a potential mechanism. The SS rat is a model of low renin hypertension 21 that responds poorly to RAS inhibition; [22] [23] [24] [25] [26] leading some to argue that Renin is unlikely a candidate BP gene. 2 However, a recent Renin knockout rat generated by our group on the SS background significantly lowered BP and renal function, 27 suggesting that even at relatively low expression levels in the SS rat, Renin is necessary for maintaining BP and renal homeostasis. Therefore, it remains plausible that a differentially expressed Renin allele would cosegregate with BP in the SS rat. Genetic elements linked to the BN and SR Renin alleles restore normal RAS function in the line 9 13, 19 and S/ren rr congenic strains, indicating that BN and SR variant(s) regulate renin expression differently than SS. In line 9, the BN Renin allele restored normal renin expression, 13 renin-dependent angiogenesis, 13 and renin-dependent vasoreactivity.
14 Likewise, normal plasma renin activity, 19 angiogenesis, 19 and vasoreactivity 20 were restored in the S/ren rr congenic rat. Introgression of the SS Renin allele into the SR background in a SR-13 SS Renin congenic strain significantly decreased plasma renin activity and kidney renin expression. 12 Thus, based solely on renin expression and renin-dependent physiological mechanisms (eg, vascular density and peripheral resistance), Renin should remain a candidate gene for genetic hypertension. Of note, however, the BN and SR Renin alleles in line 9 and S/ren rr did not lower BP (Figure 2 ), as would be expected to coincide with restored plasma renin activity and decreased peripheral resistance. 14, 20 Thus, in addition to Renin, it is likely that another gene could contribute to BP differences in the line 9 region, possibly through complex interactions with Renin. This is further supported by evidence that the BP protective region around Renin region (chr13: 46.1-47.2) did not offset BP driven by the hypertensive allele(s) in line9 BP2 in S/ren rr , 11 as was observed in line 9 ( Figure 2 ). This indicates that despite the evidence that shared BN and SR allele(s) restore renin expression, 13, 19 angiogenesis, 13, 19 and vasoreactivity 14, 20 in line 9 and S/ren rr , there likely exist other renin-independent BP allele(s) that are not shared by the SR in the line9 BP1 region.
Renin Is Part of a Compound BP QTL
Renin has long been suspected to reside in a compound BP QTL, with multiple normotensive and hypertensive alleles that can be derived from a single strain. 2 Our data indicate that at least 2 loci around Renin modulate BP (Figure 1 ). In addition to the BN protective Renin region (46.1-47.2 Mb), we also identified a BN hypertensive region (47.2-49.0 Mb), which in lines 9 and 9C masked the protective allele(s) that were observed in line 9A (Figure 1 ). Similar to line 9, the S/ren rr congenic unexpectedly failed to lower BP compared with SS. 11 The SR had a region (47.9-48.1 Mb) that was significantly enriched for common BN and SR alleles (Figure 3 ), suggesting that this overlapping BN and SR region are potentially functionally relevant.
The BP-associated Renin allele that was first identified by Rapp et al 4 in 1989 turned out to be part of a much larger BP QTL (chr13: 35-111 Mb) 5 that encompasses multiple BP loci on chromosome 13 in the SS 5 and other hypertensive strains (eg, SHR 28 and LH 29 ). Using overlapping SS-13 BN congenics, we have now identified at least 4 BP loci (published here and elsewhere) [15] [16] [17] that overlap with the Renin BP QTL identified by linkage. 5, 28, 29 Specifically, our data suggest the existence of 17 Similar compound BP QTLs have also been reported for rat chromosomes 1, 2, 3, 5, 9, and 10, 3 indicating that the complex genetic architecture within a QTL has a much greater impact on BP than originally anticipated.
For purposes of illustration, we have highlighted the published chromosome 13 BP QTL and congenic strains in Figure 4 . Rapp's initial SS×SR crosses were followed up by congenic SS-13 SR strains: S.R-Ren(a), S.R-Ren(b), and S.RRen. 5 Of these strains, only S.R-Ren (1-78 Mb) decreased BP (Δ-24 mm Hg) compared with parental SS, whereas S.R-Ren(a) and S.R-Ren(b) did not. 5 On the basis of our congenic data, the S.R-Ren region includes 2 protective BP loci (line 9 BP1 and line 26) and 1 hypertensive locus (line9 BP2 ) that collectively lower BP in the SS rat. A reverse congenic (congenic R) published by St. Lezin et al 12 contains the SS Renin allele, yet significantly lowered BP, possibly owing to the presence of the SR region overlapping with the line 26 QTL. The S/ren rr congenic that increased BP (Δ+34 mm Hg) compared with SS 4 includes only the hypertensive locus (line9 BP2 ), resulting in significantly elevated BP compared with SS parental (Figure 2 ). Our smallest protective congenic, line 9A (45.2-47.3 Mb), includes only the protective Renin region (chr13: 46.1-47.2 Mb). When combined, these data support the following: (1) BP QTL intervals identified by linkage are not always single entities, but rather the sums of multiple interdependent loci; (2) unexpectedly losing or gaining a BP phenotype by congenic mapping can be, in part, due to different combinations of interdependent loci, not necessarily the inclusion/exclusion of a causative variant; and (3) within a QTL, the +BP and -BP loci are not necessarily derived from the corresponding hypertensive or normotensive parental strain. In the case of the Renin QTL, 5 future studies using compound congenics or multiple gene knockout strains 30 will be needed to further validate these hypotheses.
Other Candidate Genes in Line9 BP1 and Line9 BP2 QTLs
In addition to Renin, several other potential candidate genes reside in the line9 BP1 QTL. Within the line9 BP1 QTL, we found 5 nonsynonymous amino acid changes between SS and BN or SR that were predicted to be damaging, of which 4 were specific to BN (Table) . Plekha6 and Mybph have no previously reported roles in BP or renal function. Plekha6 is a poorly characterized member of the pleckstrin homology domain-containing family A. Mybph is a myosin binding protein that also interacts with Rock1 31 and the sarcomeric myosin heavy chain. 32 Chit1 is an interesting candidate because of its reported connection to RAS; 13 however, no direct role for Chit1 in BP has been reported. Chit1 is a proinflammatory protein that is secreted by activated macrophages 33 and linked to multiple inflammatory diseases, 34 indicating that Chit1 might also contribute to chronic inflammation associated with hypertension and other cardiovascular disease.
In the line9 BP2 QTL, we identified 26 nonsynonymous amino acid changes between SS and BN or SR, of which Lgr6, Gpr37l1, Ptprv, Rnpep, and Ipo9 were predicted by PolyPhen2 to be damaging (Table) . Of these, only Rnpep (also known as aminopeptidase B) has a known role in BP and renal function by modulating RAS through conversion of AngIII to AngIV. 35 In comparison, Lgr6, Gpr37l1, Ipo9, and Ptprv have no reported roles in BP or renal function. Lgr6 and Gpr37l1 (also known as Endothelin B receptor-like protein 2) are poorly characterized G-protein-coupled receptors. Ipo9 is a nuclear importin that functions as general transporter of nuclear cargo. 36 Ptprv is a p53-regulated transmembrane tyrosine phosphatase involved in cell-cycle regulation. 37 Despite lack of functional evidence, Ptprv makes an interesting candidate because it is highly enriched for common BN and SR nonsynonymous variants (7 of 8), of which 1 was predicted to damage Ptprv function (Table) .
Perspectives
The chromosome 13 BP QTL that harbors Renin was first discovered nearly 25 years ago by Rapp et al 4 and has been independently replicated by multiple other groups. [6] [7] [8] [9] [10] Still, the genetic mechanism(s) underlying this QTL have remained controversial because of conflicting data from several congenic mapping studies. 4, 5, 12 Here, we presented congenic mapping and sequence analysis that reconciles these conflicting reports and confirms that multiple interdependent loci influence the chromosome 13 BP QTL. [6] [7] [8] [9] [10] Moreover, using archived DNA samples from the previously published S/ren rr strain, 11 we were able to reduce the list of BP candidates that could be shared by SS-13 SR and SS-13 BN congenic strains with similar phenotypes. Thus, our study not only provides novel insight to the regions around Renin that contribute to the chromosome 13 BP QTL but also highlights the use of archived experimental samples that can be reanalyzed on need or on the advent of technological advances (eg, NextGen sequencing). Regarding the line9 BP1 and line9 BP2 QTLs, further congenic mapping or testing of candidate gene function by targeted mutagenesis 30 will be needed to resolve the loci and elucidate the specific variant(s) that impact BP in this region.
What Is New?
• We identified 2 novel BP loci: a protective region (chr13: 46.1-47.2 Mb), which is offset by an adjacent hypertensive region (chr13: 47.2-49.0 Mb). These data provide direct evidence that multiple interdependent loci mediate overall susceptibility to hypertension at the much larger Renin quantitative trait locus that was originally described by Rapp et al. 4 • Our reanalysis of the S/ren rr congenic (Dahl R Renin region on a saltsensitive background) provides a novel comparison of the common and unique salt-sensitive, Dahl R, and Brown Norway variants. On the basis of these data, we were able to preliminarily reduce by 42% the number of potential candidate variants within the 2 BP loci and prioritize these variants for further study.
What Is Relevant?
• Renin has long been associated with genetic hypertension, but the mechanism(s) underlying this relationship are largely unknown.
• Here, we presented data, in the context of +20 years of literature, which provide a more complete picture of at least 4 BP loci that reside within the Renin quantitative trait locus, offering novel insights to the genetic elements that mediate susceptibility to hypertension.
Summary
The region surrounding Renin (chr13: 45.2-49.0 Mb) contains at least 2 counteracting loci that mediate overall susceptibility to hypertension. Combined with previous studies, these data suggest that a total of 4 BP loci reside within the 30-cM Renin quantitative trait locus.
Novelty and Significance
